Metafort-G 853 Tablet PR contains a combination of Glimepiride 3mg and Metformin 850mg in prolonged-release tablet form. It belongs to the ANTI DIABETIC category and is manufactured and marketed by Eris Lifesciences Ltd.
Composition
- Glimepiride: 3mg
- Metformin: 850mg
Product Information
- Product Name: Metafort-G 853 Tablet PR
- Generic: Glimepiride 3mg + Metformin 850mg
- Dosage Form: Prolonged-Release Tablet
- Manufacturer: Eris Lifesciences Ltd
- Marketer: Eris Lifesciences Ltd
- Category: ANTI DIABETIC
About Glimepiride and Metformin
Glimepiride is a sulfonylurea antidiabetic medicine that helps lower blood glucose by stimulating the pancreas to release insulin.
Metformin is an oral antidiabetic medicine that helps reduce blood glucose levels, primarily by decreasing glucose production in the liver and improving insulin sensitivity.
Usage Information
Use Metafort-G 853 Tablet PR only as directed by your doctor or healthcare professional. Swallow the prolonged-release tablet as instructed and follow the prescribed dosage and schedule.
For complete product information, including dosage, storage instructions, precautions, contraindications, and expiry details, refer to the original packaging before use.
